Hanger (HNGR) Peer Comparison

$18.72

$0.00 (0.00%)

As on 03-Oct-2022 09:30EDT

Market cap

$732 Mln

Revenue (TTM)

$1,176 Mln

P/E Ratio

19.7

P/B Ratio

5.8

Div. Yield

0 %

Edit

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Market cap ($ Mln)	732	9,025	4,621
Revenue ($ Mln)	1,176	3,497	235
Net Profit ($ Mln)	37.29	-76.95	-322.46
Net Margin (%)	3.17	-2.21	-151.76
RoE (%)	31.69	-2.35	-204.89
Price to Earnings	19.71	--	--
Price-To-Book	5.85	2.74	39.05

Income Statement ($ Mln)

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Operating Revenue	1,175.52	3,497.43	234.86
Cost of Revenue	387.78	1,641.83	4.45
Gross Profit	722.91	1,558.81	191.43
Operating Expenses	576.77	2,563.47	529.65
Operating Profit (EBIT)	68.80	119.92	-299.24
Other Income	0.00	-14.62	-22.38
Profit before Tax	38.86	-126.43	-321.62
Provision for Tax	1.57	-4.26	0.84
Profit after Tax (Net Income)	37.29	-76.95	-322.46
Minority Interest	0.00	0.00	0.00
Consolidated Profit	37.29	-76.95	-322.46

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Shareholder's Funds	125.21	3,290.89	118.36
Minority Interest	0.00	0.00	0.00
Non-Current Liabilities	611.10	5,413.29	658.99
Current Liabilities	230.56	932.81	93.09
Total Liabilities	998.14	10,112.62	939.21

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Non-Current Assets	683.96	8,490.58	230.43
Current Assets	282.91	1,146.40	640.01
Total Assets	998.14	10,112.62	939.21
Total Debt*	628.21	4,559.86	658.39
Net Current Assets	52.35	213.60	546.92

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Cash From Operating Activities	36.21	586.20	-256.81
Cash Flow from Investing Activities	-102.49	-568.03	12.11
Cash from Financing Activities	-16.63	-294.34	434.34
Net Cash Inflow / Outflow	-82.91	-297.30	189.63

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
ROCE (%)	5.89	-1.37	-42.51
ROE (%)	31.69	-2.35	-204.89
ROA (%)	3.17	-0.71	-39.06
EBIT Margin (%)	5.80	4.30	-126.62
Net Margin (%)	3.17	-2.21	-151.76
Cash Profit Margin (%)	0.00	0.00	0.00

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Revenue Growth (%)	11.71	7.15	42.53
EBIT Growth (%)	7.00	-2.68	-17.25
Net Profit Growth (%)	25.50	-34.72	-21.13
EPS Growth (%)	24.61	-33.09	-16.45
Book Value Growth (%)	95.76	-0.41	-64.79

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Price / Earnings	16.90	-63.22	-6.08
Price / Book Value	6.44	2.18	9.39
Dividend Yield (%)	--	--	--
EV/EBITDA	13.39	17.06	-6.53
Market Cap ($ Cr)	--	--	--

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Debt to Equity	3.66	1.36	4.92
Short term debt to equity ratio	0.40	0.01	0.05
Current Ratio	1.23	1.23	6.88
Quick Ratio	0.85	1.23	6.17
Interest Coverage	2.33	0.45	-12.02

	Hanger (HNGR)	Change Healthcare (CHNG)	Global Blood Therapeutics (GBT)
Debtors to sales (%)	13.40	20.52	12.67
Asset Turnover	1.00	0.32	0.28
Receivable days	48.83	102.75	43.42
Inventory Days	75.28	--	5,420.65
Payable days	59.10	14.98	1,882.15
Cash Conversion Cycle	65.02	--	3,581.91

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.